Hospital-Acquired Infection Control Market Size, Share, Growth, Forecast 2034

Hospital-Acquired Infection Control Industry Prospective:

The global hospital-acquired infection control market size was worth around USD 21.10 Billion in 2024 and is predicted to grow to around USD 40.74 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 6.8% between 2025 and 2034. The report analyzes the global hospital-acquired infection control market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the hospital-acquired infection control industry.

Request Free Sample

Hospital-Acquired Infection Control Market: Overview

Hospital-acquired infection (HAI) is a term used for infections that are acquired due to medical procedures or during medical care. The infections may occur in a rehabilitation facility, while receiving medical treatment for a wound, in an outpatient surgery center, hospital, or any other treatment facility. HAI occurs when bacteria or virus is able to enter a patient's body which generally happens through a wound or devices like a catheter. It may also occur due to the lungs' exposure to the bacteria.

HAI is widespread due to the presence of a variety of microorganisms like fungi, bacteria, viruses, or parasites and the infections can be of different types including ear infections, eye infections, sexually transmitted diseases, intestinal infections, lungs or respiratory disorders. HAI control refers to measures or ways of preventing the spread of such infections amongst patients.

The global hospital-acquired infection control market is a high revenue market because of various measures taken to detect HAI and develop strategies or methods to curb these infections given the threat hospital-acquired infections pose to a patient’s safety.

Key Insights

• As per the analysis shared by our research analyst, the global hospital-acquired infection control market is estimated to grow annually at a CAGR of around 6.8% over the forecast period (2025-2034).
• Regarding revenue, the global hospital-acquired infection control market size was valued at around USD 21.10 Billion in 2024 and is projected to reach USD 40.74 Billion by 2034.
• The hospital-acquired infection control market is projected to grow at a significant rate due to rising awareness of infection prevention, strict healthcare regulations, increasing hospital admissions, and advancements in disinfection technologies.
• Based on Product & Service, the Sterilization (Heat Sterilization Equipment segment is expected to lead the global market.
• On the basis of Infection Type, the Hospital-Acquired Pneumonia segment is growing at a high rate and will continue to dominate the global market.
• Based on the End User, the Hospitals & Clinics segment is projected to swipe the largest market share.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Request Free Sample

Covid-19 Impact

The global market was one of the few segments that was impacted positively during Covid-19 due to increased focus on maintaining personal hygiene, maintaining as much sterilization or cleanliness of equipment as possible, and preventing any unnecessary infections because of the number Covid-19 patients was already high.

Hospital-Acquired Infection Control Market: Growth Drivers

Increasing number of incisional procedures to propel market growth

With advancements in technology, the healthcare sector has managed to grow exponentially in the last couple of years with the opening of multiple treatment facilities thus making healthcare accessible to a larger section of society. This in turn has propelled the number of surgical operations being carried out across the globe since the treatments have become more affordable owing to better reimbursement policies and government initiatives to upgrade the healthcare infrastructure of their country with the rising disposable income of the population in many regions. The increasing cases of incisional procedures leave the patients more vulnerable to HAS which in turn forces the healthcare authorities to have better control over the spread of such infections thus aiding the global hospital-acquired infection control market growth.

There is a significant increase in the geriatric population along with increasing medical cases of chronic diseases like cancer, respiratory disorders, heart problems, and others which assist in the global market expansion. These incidents are also coupled with the demand and need for upgrading the sterilization and disinfection process in medical facilities propelled by stringent rules laid down by governments to maintain safety standards in hospitals and clinics giving a positive push to the global market expansion.

Hospital-Acquired Infection Control Market: Restraints

Safety concerns related to reusable medical equipment to restrain the market growth

Many hospitals or medical facilities utilize reusable equipment for medical procedures since they are less expensive and create less wastage. However, if reusable equipment like an endoscope, stethoscope, etc. are not thoroughly sterilized post-use, the chances of spreading hospital-acquired infections become very high thus restraining the global market growth. This is due to the withholding of tissues, blood, and other body components on the equipment allowing microbial growth and resulting in the spread of HAIs.

Another reason for restraining the global hospital-acquired infection control market growth is the adverse effects of disinfectants and sterilizing solutions on patients’ health.

Hospital-Acquired Infection Control Market: Opportunities

Growth in utilization of single-use equipment and introduction of ethylene oxide as a sterilizer to provide growth opportunities for market expansion

Owing to the rising awareness about the utilization of single-use pieces of equipment along with an increasing number of manufacturers producing or investing in R&D of single-use equipment is expected to provide multiple growth opportunities in the global hospital-acquired infection control market.

Even though ethylene oxide is considered a carcinogenic agent and CDC has mentioned that prolonged exposure to ethylene oxide may lead to cancer, there has been a growth in exhaustive R&D for reintroducing ethylene oxide as a sterilizing agent for medical equipment since it is one of the most effective gaseous sterilization substance. Various modes and techniques to use the compound in medical equipment disinfection procedures are being researched, which is also propelled by the growth in the number of patients infected by Covid-19 and the adoption of large-scale sterilization procedures.

Hospital-Acquired Infection Control Market: Challenges

Complexity of disinfecting advanced medical equipment to pose challenges in the market

Due to technical advancement, there is a considerable change in the equipment technology as well as a rise in the number of extremely advanced medical tools like analyzers, endoscopes, and others. With this, comes the need for developing advanced sterilization procedures or products that can efficiently manage to disinfect such tools which may pose challenges in the global market expansion.

Hospital-Acquired Infection Control Market: Segmentation

The global hospital-acquired infection control market is segmented based on infection type, products & services, end-user, and region.

By infection type, the global market is segmented into bloodstream infections, hospital-acquired pneumonia, infections, gastrointestinal infections, surgical site, UTIs, and others. The segment is expected to be dominated by urinary tract infections.

By product & services, the global market is segmented into protective barriers, cleaning & disinfection products, sterilization, and endoscope reprocessing products. The segment may be dominated by protective barriers since they dominated the market in 2020 and have been following the same trend.

By end-user, the global market segments are ambulatory surgical centers, hospitals & clinics, and others. The segment is expected to be led by ambulatory surgical centers with the highest CAGR during the forecast period.

Recent Developments:

• In September 2021, a partnership between Sodexo and Ecolab Inc. emerged for the prevention of HAIs. The partnership has resulted in a new program called Protecta Plus which assists hospitals and medical clinics in better prevention of hospital-acquired infections in the USA.
• In November 2021, the acquisition of Regulatory Compliance Associates (RCA) by Sotera Health Company has aided the expansion of quality, technical consulting, and regulatory capabilities in the USA.

Hospital-Acquired Infection Control Market: Report Scope    

Hospital-Acquired Infection Control Market: Regional Landscape

North America to dominate the global market during the projection period

North America dominated the global hospital-acquired control market in 2021 with over 39% of the global market share. The same trend is expected in the future owing to excellent strategic decisions and collaborations between healthcare facilities and manufacturers to expand their user database. The rigorous initiatives by private companies to penetrate markets like Africa and the Middle East are expected to aid regional growth in the coming years.

Request Free Sample

Asia-Pacific is expected to generate high CAGR in the coming years owing to an increased number of medical facilities thus propelling the use of HAI control methods, strict government regulations to maintain safety standards, and generally improving healthcare infrastructure. Asia Pacific Society of Infection Control is a non-government body aiding research on the prevention of the spread of HAIs.

Europe is expected to grow significantly because of the rising number of surgical medical cases and developed healthcare facilities.

Hospital-Acquired Infection Control Market: Competitive Space

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the hospital-acquired infection control market on a global and regional basis.

The global Hospital-Acquired Infection Control market profiles key players such as:

• MMM Group
• 3M Company
• Fortive
• Matachana Group
• Steris Plc
• Belimed AG
• Ecolab Inc
• Miele Group
• Sotera Health LLC
• Getinge AB
• Reckitt Benckiser
• Continental Equipment Company, and Pal International
• Contec, In
• C.B.M. S.r.l. Medical Equipment

Global hospital-acquired infection control market is segmented as below:

By Infection type

• Bloodstream Infections
• Hospital-acquired Pneumonia
• Infections
• Gastrointestinal Infections
• Surgical Site
• UTIs
• Others

By Products & Services

• Protective Barriers
• Cleaning & Disinfection Products
• Sterilization
• Endoscope Reprocessing Products

By End-user

• Surgical Centers
• Hospitals & Clinics
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa